19-7647436-G-T
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM2PM5PP3_StrongPP5_Moderate
The NM_006949.4(STXBP2):c.1621G>T(p.Gly541Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,613,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G541S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_006949.4 missense
Scores
Clinical Significance
Conservation
Publications
- familial hemophagocytic lymphohistiocytosis 5Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- hereditary hemophagocytic lymphohistiocytosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- microvillus inclusion diseaseInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| STXBP2 | NM_006949.4 | c.1621G>T | p.Gly541Cys | missense_variant | Exon 18 of 19 | ENST00000221283.10 | NP_008880.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| STXBP2 | ENST00000221283.10 | c.1621G>T | p.Gly541Cys | missense_variant | Exon 18 of 19 | 1 | NM_006949.4 | ENSP00000221283.4 | ||
| ENSG00000268400 | ENST00000698368.1 | n.*1724G>T | non_coding_transcript_exon_variant | Exon 20 of 20 | ENSP00000513686.1 | |||||
| ENSG00000268400 | ENST00000698368.1 | n.*1724G>T | 3_prime_UTR_variant | Exon 20 of 20 | ENSP00000513686.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000403 AC: 1AN: 248156 AF XY: 0.00000743 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461152Hom.: 0 Cov.: 77 AF XY: 0.00000275 AC XY: 2AN XY: 726882 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74348 show subpopulations
ClinVar
Submissions by phenotype
Familial hemophagocytic lymphohistiocytosis 5 Pathogenic:1
This sequence change replaces glycine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 541 of the STXBP2 protein (p.Gly541Cys). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with STXBP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 969042). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt STXBP2 protein function with a positive predictive value of 95%. This variant disrupts the p.Gly541 amino acid residue in STXBP2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 20558610, 20798128, 20823128, 23687090, 24194549). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at